Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yufei Xiang

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Frontiers of Medicine|July 31, 2012
Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflectionYu Liao, Yufei Xiang, Zhiguang Zhou
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2019
Chemical Cross-Linking and Mass Spectrometric Analysis of the Endogenous Yeast Exosome ComplexesYufei Xiang, Zhuolun Shen, Yi Shi
Clinical Reviews in Allergy & Immunology|August 4, 2014
Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive reviewTingting Tan, Yufei Xiang, Christopher Chang, et al.
Biorxiv : the Preprint Server for Biology|August 10, 2021
<i>Llamanade</i> : an open-source computational pipeline for robust nanobody humanizationZhe Sang, Yufei Xiang, Ivet Bahar, et al.
Structure (London, England : 1993)|December 13, 2021
Llamanade: An open-source computational pipeline for robust nanobody humanizationZhe Sang, Yufei Xiang, Ivet Bahar, et al.
Diabetes/Metabolism Research and Reviews|July 19, 2019
Past, present and future of latent autoimmune diabetes in adultsBingwen Liu, Yufei Xiang, Zhenqi Liu, et al.
Journal of Diabetes|March 2, 2013
Latent autoimmune diabetes in adults in Asians: similarities and differences between East and WestYufei Xiang, Zhiguang Zhou, Chao Deng, et al.
Current Opinion in Immunology|November 6, 2010
To B or not to B--pathogenic and regulatory B cells in autoimmune diabetesF Susan Wong, Changyun Hu, Yufei Xiang, et al.
Preventive Cardiology|January 5, 2008
Statin pretreatment is protective despite an association with greater coronary artery disease burden in patients presenting with a first ST-elevation myocardial infarctionLynn Moran, Tyler Fugate, Yufei Xiang, et al.
Journal of Autoimmunity|April 16, 2020
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?Bingwen Liu, Min Li, Zhiguang Zhou, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Frontiers of Medicine|July 31, 2012
Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflectionYu Liao, Yufei Xiang, Zhiguang Zhou
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2019
Chemical Cross-Linking and Mass Spectrometric Analysis of the Endogenous Yeast Exosome ComplexesYufei Xiang, Zhuolun Shen, Yi Shi
Clinical Reviews in Allergy & Immunology|August 4, 2014
Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive reviewTingting Tan, Yufei Xiang, Christopher Chang, et al.
Biorxiv : the Preprint Server for Biology|August 10, 2021
<i>Llamanade</i> : an open-source computational pipeline for robust nanobody humanizationZhe Sang, Yufei Xiang, Ivet Bahar, et al.
Structure (London, England : 1993)|December 13, 2021
Llamanade: An open-source computational pipeline for robust nanobody humanizationZhe Sang, Yufei Xiang, Ivet Bahar, et al.
Diabetes/Metabolism Research and Reviews|July 19, 2019
Past, present and future of latent autoimmune diabetes in adultsBingwen Liu, Yufei Xiang, Zhenqi Liu, et al.
Journal of Diabetes|March 2, 2013
Latent autoimmune diabetes in adults in Asians: similarities and differences between East and WestYufei Xiang, Zhiguang Zhou, Chao Deng, et al.
Current Opinion in Immunology|November 6, 2010
To B or not to B--pathogenic and regulatory B cells in autoimmune diabetesF Susan Wong, Changyun Hu, Yufei Xiang, et al.
Preventive Cardiology|January 5, 2008
Statin pretreatment is protective despite an association with greater coronary artery disease burden in patients presenting with a first ST-elevation myocardial infarctionLynn Moran, Tyler Fugate, Yufei Xiang, et al.
Journal of Autoimmunity|April 16, 2020
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?Bingwen Liu, Min Li, Zhiguang Zhou, et al.
Pageof 9